FDA Inspection 1050210 — ADMI
The FDA completed an inspection of ADMI on April 17, 2018 in East Syracuse, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- East Syracuse, NY (United States)